BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38471994)

  • 1. [Dabrafénib and tramétinib in BRAF V600E mutated pediatric gliomas].
    Giorgis O; Doz F
    Bull Cancer; 2024 May; 111(5):429-430. PubMed ID: 38471994
    [No Abstract]   [Full Text] [Related]  

  • 2. Dabrafenib Effective in Pediatric Glioma.
    Cancer Discov; 2017 Jan; 7(1):OF5. PubMed ID: 28062673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabrafenib plus trametinib in patients with BRAF
    Wen PY; Stein A; van den Bent M; De Greve J; Wick A; de Vos FYFL; von Bubnoff N; van Linde ME; Lai A; Prager GW; Campone M; Fasolo A; Lopez-Martin JA; Kim TM; Mason WP; Hofheinz RD; Blay JY; Cho DC; Gazzah A; Pouessel D; Yachnin J; Boran A; Burgess P; Ilankumaran P; Gasal E; Subbiah V
    Lancet Oncol; 2022 Jan; 23(1):53-64. PubMed ID: 34838156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabrafenib and trametinib in BRAFV600E mutated glioma.
    Brown NF; Carter T; Kitchen N; Mulholland P
    CNS Oncol; 2017 Oct; 6(4):291-296. PubMed ID: 28984141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Therapy Win in BRAF-Mutant Gliomas.
    Cancer Discov; 2023 Nov; 13(11):2299-2300. PubMed ID: 37732735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical response to dabrafenib plus trametinib in a pediatric ganglioglioma with
    Miller KE; Schieffer KM; Grischow O; Rodriguez DP; Cottrell CE; Leonard JR; Finlay JL; Mardis ER
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33637608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.
    Menzies AM; Long GV
    Clin Cancer Res; 2014 Apr; 20(8):2035-43. PubMed ID: 24583796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabrafenib plus trametinib in patients with BRAF
    Davies MA; Saiag P; Robert C; Grob JJ; Flaherty KT; Arance A; Chiarion-Sileni V; Thomas L; Lesimple T; Mortier L; Moschos SJ; Hogg D; Márquez-Rodas I; Del Vecchio M; Lebbé C; Meyer N; Zhang Y; Huang Y; Mookerjee B; Long GV
    Lancet Oncol; 2017 Jul; 18(7):863-873. PubMed ID: 28592387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoid-like reaction in a child following prolonged therapeutic exposure to dabrafenib and trametinib for BRAF V600E mutated hypothalamic/chiasmatic glioma.
    Wilhelmsson M; Chun FJ; Yeung RSM; Krtizinger F; McKeown T; Coblentz A; Ertl-Wagner B; Tabori U; Bartels U; Das A
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30619. PubMed ID: 37555268
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With
    Johanns TM; Ferguson CJ; Grierson PM; Dahiya S; Ansstas G
    J Natl Compr Canc Netw; 2018 Jan; 16(1):4-10. PubMed ID: 29295876
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation.
    Meng P; Koopman B; Kok K; Ter Elst A; Schuuring E; van Kempen LC; Timens W; Hiltermann TJN; Groen HJM; van den Berg A; van der Wekken AJ
    Lung Cancer; 2020 Aug; 146():358-361. PubMed ID: 32534795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabrafenib-trametinib is effective in paediatric high-grade glioma.
    Romero D
    Nat Rev Clin Oncol; 2023 Nov; 20(11):734. PubMed ID: 37726419
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib.
    Marks AM; Bindra RS; DiLuna ML; Huttner A; Jairam V; Kahle KT; Kieran MW
    Pediatr Blood Cancer; 2018 May; 65(5):e26969. PubMed ID: 29380516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage chemotherapy after failure of targeted therapy in a child with BRAF V600E low-grade glioma.
    Raswoli M; Nobre L; Hawkins C; Bartels UK; Tabori U; Bouffet E
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28561. PubMed ID: 32681754
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric
    Bouffet E; Geoerger B; Moertel C; Whitlock JA; Aerts I; Hargrave D; Osterloh L; Tan E; Choi J; Russo M; Fox E
    J Clin Oncol; 2023 Jan; 41(3):664-674. PubMed ID: 36375115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabrafenib-trametinib moves to the first line in low-grade glioma.
    Romero D
    Nat Rev Clin Oncol; 2023 Dec; 20(12):817. PubMed ID: 37816934
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma.
    Geukes Foppen MH; Boogerd W; Blank CU; van Thienen JV; Haanen JB; Brandsma D
    Melanoma Res; 2018 Apr; 28(2):126-133. PubMed ID: 29356790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma.
    Piña Y; Fusco MJ; Macaulay RJ; Walko CM; Peguero E; Evernden BR; Smalley KS; Forsyth P
    J Neurol; 2020 Mar; 267(3):783-790. PubMed ID: 31748891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabrafenib plus trametinib in patients with previously untreated BRAF
    Planchard D; Smit EF; Groen HJM; Mazieres J; Besse B; Helland Å; Giannone V; D'Amelio AM; Zhang P; Mookerjee B; Johnson BE
    Lancet Oncol; 2017 Oct; 18(10):1307-1316. PubMed ID: 28919011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of dabrafenib plus trametinib in patients with BRAF
    Rizzo A; Ricci AD; Brandi G
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):506-507. PubMed ID: 33334695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.